Functional temozolomide sensitivity testing of patient-specific glioblastoma stem cell cultures is predictive of clinical outcome-Reference-Cited by-同舟云学术

Functional temozolomide sensitivity testing of patient-specific glioblastoma stem cell cultures is predictive of clinical outcome

Published:2022-12 Issue: Volume:26 Page:101535
ISSN:1936-5233
Container-title:Translational Oncology
language:en
Short-container-title:Translational Oncology

Author:

Skaga Erlend^ORCID,Kulesskiy Evgeny^ORCID,Potdar Swapnil,Panagopoulos Ioannis,Micci Francesca^ORCID,Langmoen Iver A.,Sandberg Cecilie J.,Vik-Mo Einar O.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference44 articles.

1. Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines;Lee;Cancer Cell,2006

2. Glioblastoma stem cells: driving resilience through chaos;Prager;Trend. Cancer,2020

3. Brain tumor stem cells maintain overall phenotype and tumorigenicity after in vitro culturing in serum-free conditions;Vik-Mo;Neuro-oncol.,2010

4. Maintenance of primary tumor phenotype and genotype in glioblastoma stem cells;Wakimoto;Neuro-oncol.,2012

5. Genomic and phenotypic characterization of a broad panel of patient derived xenografts reflects the diversity of glioblastoma;Vaubel;Clin. Cancer Res.,2019

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nanomedicine facilitated cell signaling blockade: difficulties and strategies to overcome glioblastoma;Journal of Materials Chemistry B;2024

2. Functional and Molecular Heterogeneity in Glioma Stem Cells Derived from Multiregional Sampling;Cancers;2023-12-13